» Articles » PMID: 26708152

An Overview of Potential Molecular Mechanisms Involved in VSMC Phenotypic Modulation

Overview
Publisher Springer
Date 2015 Dec 29
PMID 26708152
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The fully differentiated medial vascular smooth muscle cells (VSMCs) of mature vessels keep quiescent and contractile. However, VSMC can exhibit the plasticity in phenotype switching from a differentiated and contractile phenotype to a dedifferentiated state in response to alterations in local environmental cues, which is called phenotypic modulation or switching. Distinguishing from its differentiated state expressing more smooth muscle (SM)-specific/selective proteins, the phenotypic modulation in VSMC is characterized by an increased rate of proliferation, migration, synthesis of extracellular matrix proteins and decreased expression of SM contractile proteins. Although it has been well demonstrated that phenotypic modulation of VSMC contributes to the occurrence and progression of many proliferative vascular diseases, little is known about the details of the molecular mechanisms of VSMC phenotypic modulation. Growing evidence suggests that variety of molecules including microRNAs, cytokines and biochemical factors, membrane receptors, ion channels, cytoskeleton and extracellular matrix play important roles in controlling VSMC phenotype. The focus of the present review is to provide an overview of potential molecular mechanisms involved in VSMC phenotypic modulation in recent years. To clarify VSMC differentiation and phenotypic modulation mechanisms will contribute to producing cell-based therapeutic interventions for aberrant VSMC differentiation-related diseases.

Citing Articles

Protease-activated receptors in vascular smooth muscle cells: a bridge between thrombo-inflammation and vascular remodelling.

Habibi A, Ruf W, Schurgers L Cell Commun Signal. 2025; 23(1):57.

PMID: 39891111 PMC: 11786455. DOI: 10.1186/s12964-025-02066-6.


The Influence of Cell Isolation and Culturing on Natriuretic Peptide Receptors in Aortic Vascular Smooth Muscle Cells.

Rager C, Klopper T, Tasch S, Whittaker M, Exintaris B, Mietens A Cells. 2025; 14(1.

PMID: 39791752 PMC: 11720613. DOI: 10.3390/cells14010051.


Phenotypic switch of vascular smooth muscle cells in COVID-19: Role of cholesterol, calcium, and phosphate.

Ghanem L, Essayli D, Kotaich J, Al Zein M, Sahebkar A, Eid A J Cell Physiol. 2024; 239(12):e31424.

PMID: 39188012 PMC: 11649971. DOI: 10.1002/jcp.31424.


Interstitial Fluid Shear Stress Induces the Synthetic Phenotype Switching of VSMCs to Release Pro-calcified Extracellular Vesicles via EGFR-MAPK-KLF5 Pathway.

Gao W, Gu K, Ma L, Yang F, Deng L, Zhang Y Int J Biol Sci. 2024; 20(7):2727-2747.

PMID: 38725857 PMC: 11077359. DOI: 10.7150/ijbs.90725.


Carrageenan maintains the contractile phenotype of vascular smooth muscle cells by increasing macromolecular crowding in vitro.

Liu Q, Jiang H, Wu Y, Li J, Sun X, Xiao C Eur J Med Res. 2024; 29(1):249.

PMID: 38650027 PMC: 11036678. DOI: 10.1186/s40001-024-01843-2.


References
1.
Xie C, Huang H, Sun X, Guo Y, Hamblin M, Ritchie R . MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev. 2010; 20(2):205-10. PMC: 3128754. DOI: 10.1089/scd.2010.0283. View

2.
Dey N, Foley K, Lincoln T, Dostmann W . Inhibition of cGMP-dependent protein kinase reverses phenotypic modulation of vascular smooth muscle cells. J Cardiovasc Pharmacol. 2005; 45(5):404-13. DOI: 10.1097/01.fjc.0000157455.38068.12. View

3.
Wang D, Chang P, Wang Z, Sutherland L, Richardson J, Small E . Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 2001; 105(7):851-62. DOI: 10.1016/s0092-8674(01)00404-4. View

4.
Zhou Z, Niu J, Zhang Z . The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells. Mol Biol Rep. 2009; 37(6):2675-86. DOI: 10.1007/s11033-009-9798-6. View

5.
Zargham R, Touyz R, Thibault G . alpha 8 Integrin overexpression in de-differentiated vascular smooth muscle cells attenuates migratory activity and restores the characteristics of the differentiated phenotype. Atherosclerosis. 2007; 195(2):303-12. DOI: 10.1016/j.atherosclerosis.2007.01.005. View